The page below is a sample from the LabCE course Overview of Prion Diseases. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Overview of Prion Diseases (online CE course) »
How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 94 CE courses, most popular
$95 Add to cart
Pick Your Courses
Up to 8 CE hours
$50 Add to cart
Histology CE Package$65 Add to cart
Individual course$20 Add to cart

Creutzfeldt-Jakob Disease (CJD)

Creutzfeldt-Jakob Disease (pronounced KROITS-felt/YAH-kohb) was diagnosed independently in the early 1920s by the two men after whom the disease was named. However, as noted earlier, the cause wasn’t understood until the late 1990s with the discovery of prions. Basically there are three types of classic prion diseases, or CJD: sporadic, familial, or inherited (although it might be debated whether sporadic and iatrogenic forms should be included in infectious prions). However, since the source of the disease is either unknown or accidental, they are categorized as classic CJDs. Sporadic CJD accounts for between 85-90% of diagnosed classic CJD cases. It is estimated that one person per million people develops the disease. Familial or inherited CJD accounts for about 10-15% of the diagnosed cases while iatrogenic CJD accounts for less than one percent of the diagnosed cases. One of the reasons that classic CJD is difficult to diagnose is because, in the early stages, the symptoms often mimic those of Alzheimer's Disease, Huntington's Disease, or Parkinson's Disease. Early symptoms for both the sporadic and iatrogenic CJD include mood swings, anxiety, memory lapses, anti-social behavior such as noticeable withdrawal, lapses in memory, a lack of coordination, and insomnia. As the disease progresses, patients generally experience marked deterioration in their vision, dementia, involuntary muscle contractions that develop into muscle paralysis, a slurring of speech, difficulty in swallowing, incontinence, and eventually coma.